HTHiroki Tsujioka

Hiroki Tsujioka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroki Tsujioka has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Kazutaka Saito

    Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan

    4 shared publications
  • Akinori Nakayama

    Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan

    3 shared publications
  • Kiyoshi Setoguchi

    Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan

    3 shared publications
  • Asumi Nirazuka

    Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan

    2 shared publications
  • Keita Izumi

    Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan

    2 shared publications
  • Kintaro Hasegawa

    Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan

    2 shared publications

Latest Publications

  • Impact of C‐Reactive Protein Kinetics on the Prognosis of the Patient With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin

    by Hiroki Tsujioka, Keita Izumi, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito


  • Comparison of Robot‐Assisted Laparoscopic Prostatectomy Using the Made‐in‐Japan Robotic System Hinotori Versus Da Vinci: A Propensity Score‐Matched Analysis

    by Hiroki Tsujioka, Kiyoshi Setoguchi, Asumi Nirazuka, Kintaro Hasegawa, Keita Izumi, Akinori Nakayama, Kazutaka Saito

    Background: We compared the surgical outcomes of patients who underwent robot‐assisted radical prostatectomy (RARP) using hinotori with those of patients who underwent RARP using da Vinci Xi through propensity score matching to evaluate the potential benefits and efficacy of hinotori.Methods: Perioperative data of patients who underwent RARP between 2017 and 2023 were retrospectively evaluated.Results: After adjusting for preoperative risk factors, each group comprised 118 propensity score‐matched patients. Both median total operative time and median console time were significantly longer in the hinotori group (median differences, 26 and 23 min, respectively). Although the hinotori group had lower estimated blood loss, no significant differences were noted between the groups in postoperative complications, positive surgical margin rates, 12‐month biochemical recurrence rates, and urinary continence recovery rates.Conclusions: Although RARP requires more time with hinotori, our study demonstrated that RARP can be performed safely and effectively immediately after the installation of hinotori.


  • Open Access

    Testicular seminoma in transverse testicular ectopia

    by Minoru Inoue, Akiyoshi Osaka, Erika Ikezoe, Hiroki Tsujioka, Asumi Nirazuka, Kintaro Hasegawa, Toshiyuki Iwahata, Akinori Nakayama, Kiyoshi Setoguchi, Kazutaka Saito

    Introduction: Transverse testicular ectopia is a rare anomaly in which both testes descend toward the same side of the hemiscrotum.Case presentation: A 35‐year‐old man presented with right inguinal enlargement. Computed tomography showed a normal testis in the right hemiscrotum and a 58 mm heterogeneous mass in the right inguinal area. No testis was observed in the left hemiscrotum. The vascular structures extended from the right inguinal mass to the left renal vein. Consequently, the left testicular tumor was diagnosed as transverse testicular ectopia, and a left orchiectomy was performed. The histological diagnosis was seminoma stage pT2. Furthermore, left para‐aortic lymph node metastasis developed 10 months postoperatively. A complete response was obtained after systemic chemotherapy.Conclusion: Awareness of seminomas in transverse testicular ectopia could facilitate appropriate diagnosis and treatment. Furthermore, the location of the lymph node metastasis indicated that the ectopic testis could have originated from the left side.


  • Open Access

    A regressed germ cell tumor discovered secondary to azoospermia

    by Hiroki Tsujioka, Keiichiro Uemura, Toshiyuki Iwahata, Yasuyuki Inoue, Minoru Inoue, Akiyoshi Osaka, Akinori Nakayama, Hiroshi Okada, Kazutaka Saito

    Introduction: Regressed germ cell tumors are a rare disease commonly diagnosed with metastatic symptoms without local symptoms in the testis.Case presentation: A 33‐year‐old man with azoospermia was referred to our hospital. His right testis was slightly swollen, and ultrasonography revealed hypoechogenicity of the right testis with decreased blood flow. Right high orchiectomy was performed. Pathologically, the seminiferous tubules were absent or highly atrophied with vitrification degeneration; however, no neoplastic lesion was confirmed. One‐month post‐surgery, the patient noticed a mass in the left supraclavicular fossa, of which a biopsy revealed seminoma. The patient was diagnosed with a regressed germ cell tumor and underwent systemic chemotherapy.Conclusion: We reported the first case of a regressed germ cell tumor discovered due to complaints of azoospermia.